Hetlioz LQ
NDC 43068-304, tasimelteon, suspension, from Vanda Pharmaceuticals Inc..
- Product NDC
- 43068-304
- Status
- Listed
- Labeler
- Vanda Pharmaceuticals Inc.
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA214517
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43068-304 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TASIMELTEON4 mg/mL
Pharmacologic classes
Melatonin Receptor Agonist [EPC]; Melatonin Receptor Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43068-304-02 | 43068030402 | 1 BOTTLE in 1 CARTON (43068-304-02) / 48 mL in 1 BOTTLE |
| 43068-304-06 | 43068030406 | 1 BOTTLE in 1 CARTON (43068-304-06) / 158 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ca4a9b63-708e-49e9-8f9b-010625443b90
Use it
Look up 43068-304 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43068-304 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43068-304. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.